Corcept Therapeutics Correlations

CORT Stock

USD 57.59 0.41 0.71%

The current 90-days correlation between Corcept Therapeutics and Halozyme Therapeutics is 0.37 (i.e., Weak diversification). The correlation of Corcept Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Corcept Therapeutics Correlation With Market

Very weak diversification

The correlation between Corcept Therapeutics Incorpora and DJI is 0.46 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Corcept Therapeutics Incorpora and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corcept Therapeutics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Moving together with Corcept Stock

0.83	OPT	Opthea	Pair Corr
0.8	CYTH	Cyclo Therapeutics	Pair Corr
0.69	FNA	Paragon 28	Pair Corr

Moving against Corcept Stock

0.78	MRK	Merck Company	Pair Corr
0.68	INBX	Inhibrx Symbol Change	Pair Corr
0.66	EYEN	Eyenovia	Pair Corr
0.6	ARQT	Arcutis Biotherapeutics	Pair Corr
0.59	DSGN	Design Therapeutics	Pair Corr
0.58	LFCR	Lifecore Biomedical	Pair Corr
0.51	ANNX	Annexon Earnings Call This Week	Pair Corr
0.41	ISPC	iSpecimen	Pair Corr
0.37	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.36	TLRY	Tilray Inc	Pair Corr
0.35	MREO	Mereo BioPharma Group	Pair Corr
0.31	CGC	Canopy Growth Corp	Pair Corr
0.48	CRNX	Crinetics Pharmaceuticals	Pair Corr

Related Correlations Analysis

	IDYA	ANAB	MGTX	KROS	FIXX	EWTX	GLUE	MLYS	ERAS	HALO
IDYA		-0.43	-0.57	0.45	0.0	0.59	0.5	-0.03	0.88	-0.89	IDYA
ANAB	-0.43		0.36	-0.22	0.0	-0.15	-0.18	-0.2	-0.54	0.54	ANAB
MGTX	-0.57	0.36		-0.22	0.0	-0.44	-0.1	0.18	-0.59	0.63	MGTX
KROS	0.45	-0.22	-0.22		0.0	0.35	0.59	0.27	0.51	-0.49	KROS
FIXX	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	FIXX
EWTX	0.59	-0.15	-0.44	0.35	0.0		0.52	0.13	0.49	-0.56	EWTX
GLUE	0.5	-0.18	-0.1	0.59	0.0	0.52		0.5	0.57	-0.54	GLUE
MLYS	-0.03	-0.2	0.18	0.27	0.0	0.13	0.5		0.3	-0.09	MLYS
ERAS	0.88	-0.54	-0.59	0.51	0.0	0.49	0.57	0.3		-0.92	ERAS
HALO	-0.89	0.54	0.63	-0.49	0.0	-0.56	-0.54	-0.09	-0.92		HALO
	IDYA	ANAB	MGTX	KROS	FIXX	EWTX	GLUE	MLYS	ERAS	HALO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ERAS	+ 0.88	IDYA
HALO	+ 0.63	MGTX
EWTX	+ 0.59	IDYA
GLUE	+ 0.59	KROS
ERAS	+ 0.57	GLUE
HALO	+ 0.54	ANAB

High negative correlations

HALO	- 0.92	ERAS
HALO	- 0.89	IDYA
ERAS	- 0.59	MGTX
MGTX	- 0.57	IDYA
HALO	- 0.56	EWTX
HALO	- 0.54	GLUE

Risk-Adjusted Indicators

There is a big difference between Corcept Stock performing well and Corcept Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Corcept Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
IDYA	2.36	(0.55)	0.00	(1.44)	0.00	0.00	4.11	(4.98)	12.18
ANAB	4.27	0.37	0.07	0.19	4.44	(5.30)	9.84	(7.48)	43.41
MGTX	3.13	0.43	0.14	(1.43)	3.47	(3.49)	5.56	(5.58)	34.28
KROS	3.98	(1.76)	0.00	(17.87)	0.00	0.00	4.41	(7.31)	73.15
FIXX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EWTX	2.97	(0.11)	0.00	(0.15)	0.00	0.00	5.32	(7.61)	26.44
GLUE	3.37	(0.19)	0.00	(0.23)	0.00	0.00	7.34	(7.69)	19.92
MLYS	4.39	0.48	0.14	(0.37)	4.39	(5.10)	10.04	(8.23)	50.53
ERAS	3.28	(0.76)	0.00	(0.60)	0.00	0.00	7.57	(8.74)	21.39
HALO	1.02	0.50	0.46	0.93	0.62	(1.21)	2.54	(1.45)	7.81

Corcept Therapeutics Corporate Management

Hazel Hunt	Chief Officer	Profile
Amy Flood	Chief Officer	Profile
Joseph MD	President, CoFounder	Profile
William PharmD	Chief Officer	Profile
Gary JD	Chief Secretary	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC